Phase 2 Small Cell Lung Cancer Extensive Stage Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)
Small Cell Lung Cancer Extensive Stage
Merck Sharp & Dohme LLC170 enrolled15 locationsNCT07227597
Recruiting
Phase 2
Multicenter, Phase II Randomized Controlled Study of Adebrelimab Combined With Chemotherapy and Concurrent Low-Dose Radiotherapy (LDRT) for the Treatment of Extensive-Stage Small Cell Lung Cancer (SCLC)
Small Cell Lung Cancer Extensive Stage
Sichuan University202 enrolled1 locationNCT06610734
Recruiting
Phase 1Phase 2
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Small Cell Lung Cancer Extensive Stage
Genprex, Inc.62 enrolled17 locationsNCT05703971
Recruiting
Phase 2
PD-L1 Inhibitor Combined With Apatinib as First-line Maintenance Treatment for Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Nanfang Hospital, Southern Medical University40 enrolled1 locationNCT06429696
Recruiting
Phase 1Phase 2
IN10018 Combination Therapy in Treatment-naïve ES-SCLC
Small Cell Lung Cancer Extensive Stage
InxMed (Shanghai) Co., Ltd.120 enrolled3 locationsNCT06030258
Recruiting
Phase 2
Study of Pembrolizumab, Lenvatinib and Chemotherapy Combination in First Line Extensive-stage Small Cell Lung Cancer
Small Cell Lung Cancer Extensive Stage
Fundación GECP46 enrolled18 locationsNCT05384015
Recruiting
Phase 2
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC
Small Cell Lung Cancer Extensive Stage
Xiaorong Dong45 enrolled1 locationNCT05745350
Recruiting
Phase 2
Liposomal Irinotecan and Apatinib in ES-SCLC
Small Cell Lung Cancer Extensive Stage
Second Affiliated Hospital, School of Medicine, Zhejiang University30 enrolled1 locationNCT06749691
Recruiting
Phase 2
Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC
Small Cell Lung Cancer Extensive Stage
Guangzhou Institute of Respiratory Disease120 enrolled1 locationNCT06739928